Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Wan

Showing results (471-480 of 491) with videos related to

Pageof 50
Sort By:
Nature Biotechnology|November 20, 2003
An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteriaXiao-Qing Qiu, He Wang, Xiao-Fong Lu, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studiesDai-Shi Su, M Kristine Markowitz, Kathy L Murphy, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2008
The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutationsThomas J Tucker, Sandeep Saggar, John T Sisko, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2006
Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone leadTheresa M Williams, Craig A Stump, Diem N Nguyen, et al.
Journal of Medicinal Chemistry|October 2, 2008
Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant virusesThomas J Tucker, John T Sisko, Robert M Tynebor, et al.
Journal of Medicinal Chemistry|February 17, 2006
Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonistsMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Nature Communications|December 18, 2023
Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injuryLi-Kai Chu, Xu Cao, Lin Wan, et al.
Eclinicalmedicine|November 5, 2020
A deep learning algorithm for detection of oral cavity squamous cell carcinoma from photographic images: A retrospective studyQiuyun Fu, Yehansen Chen, Zhihang Li, et al.
Journal of Medicinal Chemistry|November 4, 2009
Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant virusesDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 1, 2005
[Surveillance on severe acute respiratory syndrome associated coronavirus in animals at a live animal market of Guangzhou in 2004]Ming Wang, Huai-qi Jing, Hui-fang Xu, et al.
Pageof 50

Showing results (471-480 of 491) with videos related to

Sort By:
Pageof 50
Nature Biotechnology|November 20, 2003
An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteriaXiao-Qing Qiu, He Wang, Xiao-Fong Lu, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studiesDai-Shi Su, M Kristine Markowitz, Kathy L Murphy, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2008
The design and synthesis of diaryl ether second generation HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) with enhanced potency versus key clinical mutationsThomas J Tucker, Sandeep Saggar, John T Sisko, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2006
Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone leadTheresa M Williams, Craig A Stump, Diem N Nguyen, et al.
Journal of Medicinal Chemistry|October 2, 2008
Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant virusesThomas J Tucker, John T Sisko, Robert M Tynebor, et al.
Journal of Medicinal Chemistry|February 17, 2006
Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonistsMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Nature Communications|December 18, 2023
Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injuryLi-Kai Chu, Xu Cao, Lin Wan, et al.
Eclinicalmedicine|November 5, 2020
A deep learning algorithm for detection of oral cavity squamous cell carcinoma from photographic images: A retrospective studyQiuyun Fu, Yehansen Chen, Zhihang Li, et al.
Journal of Medicinal Chemistry|November 4, 2009
Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant virusesDai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 1, 2005
[Surveillance on severe acute respiratory syndrome associated coronavirus in animals at a live animal market of Guangzhou in 2004]Ming Wang, Huai-qi Jing, Hui-fang Xu, et al.
Pageof 50